Oncology/Hematology
Other Cancers
More in Other Cancers
Opinion
Alarming mental health challenges among young cancer survivors, especially males, demand action
Dec 17, 2024
Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC
Dec 04, 2024
1.00
CME Credits